Biofrontera (BFRI) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to -$0.62.
- Biofrontera's EPS (Weighted Average and Diluted) rose 3673.47% to -$0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.49, marking a year-over-year decrease of 33281.25%. This contributed to the annual value of -$3.22 for FY2024, which is 7527.38% up from last year.
- Per Biofrontera's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.62 for Q3 2025, which was up 3673.47% from -$0.57 recorded in Q2 2025.
- In the past 5 years, Biofrontera's EPS (Weighted Average and Diluted) registered a high of $4.55 during Q4 2023, and its lowest value of -$7.23 during Q2 2023.
- In the last 5 years, Biofrontera's EPS (Weighted Average and Diluted) had a median value of -$0.76 in 2022 and averaged -$1.52.
- The largest annual percentage gain for Biofrontera's EPS (Weighted Average and Diluted) in the last 5 years was 26250.0% (2023), contrasted with its biggest fall of 185053.37% (2023).
- Quarter analysis of 5 years shows Biofrontera's EPS (Weighted Average and Diluted) stood at -$2.0 in 2021, then crashed by 40.0% to -$2.8 in 2022, then skyrocketed by 262.5% to $4.55 in 2023, then tumbled by 105.56% to -$0.25 in 2024, then plummeted by 144.99% to -$0.62 in 2025.
- Its last three reported values are -$0.62 in Q3 2025, -$0.57 for Q2 2025, and -$0.47 during Q1 2025.